Pulivarthi H. Rao mainly investigates Molecular biology, Cancer research, Comparative genomic hybridization, Genetics and Gene duplication. His biological study spans a wide range of topics, including Metaphase, Cell biology, CD19 and Chromosomal translocation. His study looks at the relationship between Chromosomal translocation and topics such as Gene rearrangement, which overlap with Breakpoint.
His Cancer research research is multidisciplinary, relying on both Oncogene, Pathology, Gene mapping, Interferon regulatory factors and Multiple myeloma. He has researched Comparative genomic hybridization in several fields, including Tumor progression and Cytogenetics. His Gene duplication research integrates issues from Gene dosage, Fluorescence in situ hybridization, Amplicon and Cervical cancer.
Pulivarthi H. Rao focuses on Cancer research, Molecular biology, Genetics, Comparative genomic hybridization and Pathology. His Cancer research research includes elements of Carcinogenesis, Cancer, Regulation of gene expression and Oncogene. His Molecular biology course of study focuses on Fluorescence in situ hybridization and Genetic marker.
His work deals with themes such as Gene expression profiling, Internal medicine, Thyroid, Cytogenetics and Gene duplication, which intersect with Comparative genomic hybridization. His work carried out in the field of Gene duplication brings together such families of science as Gene dosage and Amplicon. His study in Pathology is interdisciplinary in nature, drawing from both Karyotype and Adenocarcinoma.
His main research concerns Cancer research, Osteosarcoma, Pathology, Cell culture and Gene. The various areas that Pulivarthi H. Rao examines in his Cancer research study include Carcinogenesis, Cancer, Breast cancer, Oncogene and Immunology. His Pathology study combines topics from a wide range of disciplines, such as Isochromosome, Karyotype, Chromosome abnormality, Phenotype and Cytogenetics.
In his research, Salivary duct carcinoma, Molecular biology and Androgen receptor is intimately related to PTEN, which falls under the overarching field of Telomerase reverse transcriptase. Pulivarthi H. Rao undertakes interdisciplinary study in the fields of Molecular biology and PVT1 through his research. As a part of the same scientific study, Pulivarthi H. Rao usually deals with the Chromosomal translocation, concentrating on Parotid gland and frequently concerns with Chromosome.
His primary scientific interests are in Cancer research, Osteosarcoma, Immunology, Carcinogenesis and Colorectal cancer. His research in Cancer research intersects with topics in Cancer, Cell cycle, Anaphase, Loss of heterozygosity and Tumor suppressor gene. His Cancer study is concerned with the field of Genetics as a whole.
His Osteosarcoma research is multidisciplinary, incorporating elements of Insulin-like growth factor 1 receptor, Growth factor, Penetrance and Targeted therapy. He combines subjects such as Malignancy, Transcriptome, Oncogene, RBPJ and Sarcoma with his study of Carcinogenesis. Within one scientific family, Pulivarthi H. Rao focuses on topics pertaining to Bioinformatics under Colorectal cancer, and may sometimes address concerns connected to Gene, Cell growth and Gene dosage.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification
Davide Ruggero;Silvia Grisendi;Francesco Piazza;Eduardo Rego.
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency.
Maria Barna;Aya Pusic;Ornella Zollo;Maria Costa.
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
Shinsuke Iida;Pulivarthi H. Rao;Marion Butler;Paolo Corradini.
Nature Genetics (1997)
Chromosomal and gene amplification in diffuse large B-cell lymphoma
Pulivarthi H. Rao;Jane Houldsworth;Katerina Dyomina;Nasser Z. Parsa.
Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance
Yoshitsugu Mitani;Jie Li;Pulivarthi H. Rao;Yi Jue Zhao.
Clinical Cancer Research (2010)
Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Joseph C. Presti;P. H. Rao;Q. Chen;Victor E. Reuter.
Cancer Research (1991)
REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma
Jane Houldsworth;Susan Mathew;Pulivarthi H. Rao;Katerina Dyomina.
IRTA1 and IRTA2, Novel Immunoglobulin Superfamily Receptors Expressed in B Cells and Involved in Chromosome 1q21 Abnormalities in B Cell Malignancy
Georgia Hatzivassiliou;Ira Miller;Jun Takizawa;Nallasivam Palanisamy.
p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas
Bhuvanesh Singh;Pabbathi G. Reddy;Andy Goberdhan;Christine Walsh.
Genes & Development (2002)
The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability
Michael Overholtzer;Michael Overholtzer;Pulivarthi H. Rao;Reyna Favis;Xin Yan Lu.
Proceedings of the National Academy of Sciences of the United States of America (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: